-
Je něco špatně v tomto záznamu ?
5'-Phosphonate modified oligoadenylates as potent activators of human RNase L
T. Lášek, M. Petrová, I. Košiová, O. Šimák, M. Buděšínský, J. Kozák, J. Snášel, Z. Vavřina, G. Birkuš, I. Rosenberg, O. Páv
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- adeninnukleotidy chemická syntéza chemie farmakologie MeSH
- endoribonukleasy metabolismus MeSH
- konformace nukleové kyseliny MeSH
- lidé MeSH
- oligoribonukleotidy chemická syntéza chemie farmakologie MeSH
- organofosfonáty chemická syntéza chemie farmakologie MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The oligoadenylate synthetase-ribonuclease L pathway is a major player in the interferon-induced antiviral defense mechanism of cells. Upon sensing viral dsRNA, 5'-phosphorylated 2',5'-oligoadenylates are synthesized, and subsequently activate latent RNase L. To determine the influence of 5'-phosphate end on the activation of human RNase L, four sets of 5'-phosphonate modified oligoadenylates were prepared on solid-phase. The ability of these 5'-modified oligoadenylates bearing shortened, isosteric and prolonged phosphonate linkages to activate RNase L was explored. We found that isosteric linkages and linkages prolonged by one atom were in general well tolerated by the enzyme with the EC50 values comparable to that of the natural activator. In contrast, linkages shortened by one atom or prolonged by two atoms exhibited decrease in the activity.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22010993
- 003
- CZ-PrNML
- 005
- 20230509145107.0
- 007
- ta
- 008
- 220425s2022 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bmc.2022.116632 $2 doi
- 035 __
- $a (PubMed)35078032
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Lášek, Tomáš $u IOCB Prague, Flemingovo nam. 2, 160 00 Prague, Czech Republic; UCT Prague, Technická 5, 166 28, Prague, Czech Republic
- 245 10
- $a 5'-Phosphonate modified oligoadenylates as potent activators of human RNase L / $c T. Lášek, M. Petrová, I. Košiová, O. Šimák, M. Buděšínský, J. Kozák, J. Snášel, Z. Vavřina, G. Birkuš, I. Rosenberg, O. Páv
- 520 9_
- $a The oligoadenylate synthetase-ribonuclease L pathway is a major player in the interferon-induced antiviral defense mechanism of cells. Upon sensing viral dsRNA, 5'-phosphorylated 2',5'-oligoadenylates are synthesized, and subsequently activate latent RNase L. To determine the influence of 5'-phosphate end on the activation of human RNase L, four sets of 5'-phosphonate modified oligoadenylates were prepared on solid-phase. The ability of these 5'-modified oligoadenylates bearing shortened, isosteric and prolonged phosphonate linkages to activate RNase L was explored. We found that isosteric linkages and linkages prolonged by one atom were in general well tolerated by the enzyme with the EC50 values comparable to that of the natural activator. In contrast, linkages shortened by one atom or prolonged by two atoms exhibited decrease in the activity.
- 650 _2
- $a adeninnukleotidy $x chemická syntéza $x chemie $x farmakologie $7 D000227
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a endoribonukleasy $x metabolismus $7 D004722
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a konformace nukleové kyseliny $7 D009690
- 650 _2
- $a oligoribonukleotidy $x chemická syntéza $x chemie $x farmakologie $7 D009843
- 650 _2
- $a organofosfonáty $x chemická syntéza $x chemie $x farmakologie $7 D063065
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Petrová, Magdalena $u IOCB Prague, Flemingovo nam. 2, 160 00 Prague, Czech Republic
- 700 1_
- $a Košiová, Ivana $u IOCB Prague, Flemingovo nam. 2, 160 00 Prague, Czech Republic
- 700 1_
- $a Šimák, Ondřej $u IOCB Prague, Flemingovo nam. 2, 160 00 Prague, Czech Republic
- 700 1_
- $a Buděšínský, Miloš $u IOCB Prague, Flemingovo nam. 2, 160 00 Prague, Czech Republic
- 700 1_
- $a Kozák, Jaroslav $u IOCB Prague, Flemingovo nam. 2, 160 00 Prague, Czech Republic
- 700 1_
- $a Snášel, Jan $u IOCB Prague, Flemingovo nam. 2, 160 00 Prague, Czech Republic
- 700 1_
- $a Vavřina, Zdeněk $u IOCB Prague, Flemingovo nam. 2, 160 00 Prague, Czech Republic
- 700 1_
- $a Birkuš, Gabriel, $u IOCB Prague, Flemingovo nam. 2, 160 00 Prague, Czech Republic $d 1972- $7 xx0301324
- 700 1_
- $a Rosenberg, Ivan $u IOCB Prague, Flemingovo nam. 2, 160 00 Prague, Czech Republic. Electronic address: ivan.rosenberg@uochb.cas.cz
- 700 1_
- $a Páv, Ondřej $u IOCB Prague, Flemingovo nam. 2, 160 00 Prague, Czech Republic. Electronic address: ondrej.pav@uochb.cas.cz
- 773 0_
- $w MED00000769 $t Bioorganic & medicinal chemistry $x 1464-3391 $g Roč. 56, č. - (2022), s. 116632
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35078032 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20230509145104 $b ABA008
- 999 __
- $a ok $b bmc $g 1788885 $s 1162191
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 56 $c - $d 116632 $e 20220119 $i 1464-3391 $m Bioorganic & medicinal chemistry $n Bioorg Med Chem $x MED00000769
- LZP __
- $a Pubmed-20220425
